KOREA PHARMA Co., Ltd. (KOSDAQ:032300)

KOREA PHARMA Revenue

In the year 2025, KOREA PHARMA had annual revenue of 87.60B KRW with 7.78% growth. KOREA PHARMA had revenue of 19.43B in the quarter ending December 31, 2025, a decrease of -11.44%.

• Revenue: 87.60B
• Revenue Growth: +7.78%
• P/S Ratio: 1.45
• Revenue / Employee: 653.74M
• Employees: 134
• Market Cap: 126.74B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	87.60B	6.32B	7.78%
Dec 31, 2024	81.28B	-1.96B	-2.36%
Dec 31, 2023	83.24B	2.21B	2.73%
Dec 31, 2022	81.03B	1.45B	1.83%
Dec 31, 2021	79.58B	8.07B	11.28%